Design, Synthesis, and Structure-Activity relationships of Evodiamine-Based topoisomerase (Top)/Histone deacetylase (HDAC) dual inhibitors
出版年份 2022 全文链接
标题
Design, Synthesis, and Structure-Activity relationships of Evodiamine-Based topoisomerase (Top)/Histone deacetylase (HDAC) dual inhibitors
作者
关键词
Evodiamine, Topoisomerase, Histone deacetylase, Drug design, Structure-activity relationship, Antitumor activity
出版物
BIOORGANIC CHEMISTRY
Volume 122, Issue -, Pages 105702
出版商
Elsevier BV
发表日期
2022-03-07
DOI
10.1016/j.bioorg.2022.105702
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dual-Target Inhibitors Based on HDACs: Novel Antitumor Agents for Cancer Therapy
- (2020) Tingting Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Thirty Years of HDAC Inhibitors: 2020 Insight and Hindsight
- (2020) Terence C. S. Ho et al. JOURNAL OF MEDICINAL CHEMISTRY
- Design, Synthesis, and Biological Evaluation of 4-Methyl Quinazoline Derivatives as Anticancer Agents Simultaneously Targeting Phosphoinositide 3-Kinases and Histone Deacetylases
- (2019) Kehui Zhang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Evodiamine-inspired dual inhibitors of histone deacetylase 1 (HDAC1) and topoisomerase 2 (TOP2) with potent antitumor activity
- (2019) Yahui Huang et al. Acta Pharmaceutica Sinica B
- Scaffold Hopping of Natural Product Evodiamine: Discovery of a Novel Antitumor Scaffold with Excellent Potency against Colon Cancer
- (2019) Lei Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Zinc binding groups for histone deacetylase inhibitors
- (2018) Lei Zhang et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Panobinostat and Multiple Myeloma in 2018
- (2018) Andrew J. Yee et al. ONCOLOGIST
- Combination Therapy With Histone Deacetylase Inhibitors (HDACi) for the Treatment of Cancer: Achieving the Full Therapeutic Potential of HDACi
- (2018) Amila Suraweera et al. Frontiers in Oncology
- Small Molecules Simultaneously Inhibiting p53-Murine Double Minute 2 (MDM2) Interaction and Histone Deacetylases (HDACs): Discovery of Novel Multitargeting Antitumor Agents
- (2018) Shipeng He et al. JOURNAL OF MEDICINAL CHEMISTRY
- Discovery of the First-in-Class Dual Histone Deacetylase–Proteasome Inhibitor
- (2018) Sanil Bhatia et al. JOURNAL OF MEDICINAL CHEMISTRY
- Histone Deacetylase Inhibitors as Anticancer Drugs
- (2017) Tomas Eckschlager et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat
- (2017) Lianbin Yao et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Search for Potent, Small-Molecule HDACIs in Cancer Treatment: A Decade After Vorinostat
- (2017) Chiara Zagni et al. MEDICINAL RESEARCH REVIEWS
- Scaffold Diversity Inspired by the Natural Product Evodiamine: Discovery of Highly Potent and Multitargeting Antitumor Agents
- (2015) Shengzheng Wang et al. JOURNAL OF MEDICINAL CHEMISTRY
- S4MPLE—Sampler for Multiple Protein-Ligand Entities: Methodology and Rigid-Site Docking Benchmarking
- (2015) Laurent Hoffer et al. MOLECULES
- HDAC inhibitors still need a home run, despite recent approval
- (2015) Malini Guha NATURE REVIEWS DRUG DISCOVERY
- Discovery of Novel Multiacting Topoisomerase I/II and Histone Deacetylase Inhibitors
- (2015) Shipeng He et al. ACS Medicinal Chemistry Letters
- Histone deacetylase inhibitors in cancer: What have we learned?
- (2014) James R. Whittle et al. CANCER
- Phase 1 study of oral abexinostat, a histone deacetylase inhibitor, in combination with doxorubicin in patients with metastatic sarcoma
- (2014) Edwin Choy et al. CANCER
- Polypharmacology: Challenges and Opportunities in Drug Discovery
- (2014) Andrew Anighoro et al. JOURNAL OF MEDICINAL CHEMISTRY
- Trend of Histone Deacetylase Inhibitors in Cancer Therapy: Isoform Selectivity or Multitargeted Strategy
- (2014) Lei Zhang et al. MEDICINAL RESEARCH REVIEWS
- Polypharmacology – Foe or Friend?
- (2013) Jens-Uwe Peters JOURNAL OF MEDICINAL CHEMISTRY
- Pharmacological Actions of Multi-Target-Directed Evodiamine
- (2013) Hui Yu et al. MOLECULES
- New Tricks for an Old Natural Product: Discovery of Highly Potent Evodiamine Derivatives as Novel Antitumor Agents by Systemic Structure–Activity Relationship Analysis and Biological Evaluations
- (2012) Guoqiang Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- Designed Multiple Ligands for Cancer Therapy
- (2011) N. M. O'Boyle et al. CURRENT MEDICINAL CHEMISTRY
- Unprecedented Citrinin Trimer Tricitinol B Functions as a Novel Topoisomerase IIα Inhibitor
- (2011) Lin Du et al. JOURNAL OF MEDICINAL CHEMISTRY
- Promises and challenges of anticancer drugs that target the epigenome
- (2011) Inge Verbrugge et al. Epigenomics
- Selection of Evodiamine as a Novel Topoisomerase I Inhibitor by Structure-Based Virtual Screening and Hit Optimization of Evodiamine Derivatives as Antitumor Agents
- (2010) Guoqiang Dong et al. JOURNAL OF MEDICINAL CHEMISTRY
- A Series of α-Heterocyclic Carboxaldehyde Thiosemicarbazones Inhibit Topoisomerase IIα Catalytic Activity
- (2010) He Huang et al. JOURNAL OF MEDICINAL CHEMISTRY
- Chemical phylogenetics of histone deacetylases
- (2010) James E Bradner et al. Nature Chemical Biology
- Designed Multiple Ligands: An Emerging Anti-HIV Drug Discovery Paradigm
- (2009) Peng Zhan et al. CURRENT PHARMACEUTICAL DESIGN
- A Novel Potent Nicotinamide Phosphoribosyltransferase Inhibitor Synthesized via Click Chemistry
- (2009) Giampiero Colombano et al. JOURNAL OF MEDICINAL CHEMISTRY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started